Although a large proportion of patients with obesity, type 2 diabetes and/or dyslipidemia develop steatosis (non-alcoholic fatty liver disease or NAFLD), only a small percentage of these individuals experience progressive liver disease, such as non-alcoholic steatohepatitis (NASH) and cirrhosis. Therefore, an issue of primary importance to the understanding of NAFLD remains the study of the cellular and molecular events that change the natural history of the disease from non-progressive steatosis to NASH and progressive liver disease. Our work has focused on the hypothesis that saturated fatty acids are an important determinant of disease progression in NAFLD via disruption of endoplasmic reticulum homeostasis. Data in this application demonstrate that there is a significant, positive relationship between saturated fatty acids in the liver and both liver injury and ER stress markers in morbidly obese human subjects. Using cell culture systems and dietary models of NAFLD we demonstrate that saturated fatty acids promote ER stress, liver cell death and liver injury. We have identified an ER membrane- bound protein, SERCA truncated isoform (S1T), that is upregulated by saturated fatty acids and mediates saturated fatty acid-induced ER stress and cell death, in part, via redistribution of luminal calcium stores. Thus, we hypothesize that the composition of fatty acids delivered to or stored within the liver are an important determinant of ER homeostasis and susceptibility to liver injury in NAFLD.
The specific aim of this application is to elucidate how saturated fatty acids provoke ER stress and whether and how ER stress may be linked to loss of liver cell integrity. The primary hypotheses to be tested are that 1) S1T and CCAAT-homologous protein (Chop) mediate saturated fatty acid-induced ER stress and impaired liver cell integrity; and 2) saturated fatty acids impair the folding and degradative capacities of the ER and thus the ability of the UPR to reestablish ER homeostasis following ER stress. Identification of the cellular mechanisms that determine whether excess lipid delivery to and accumulation in the hepatocyte is tolerated or cytotoxic will provide information fundamental to our understanding of disease progression in NAFLD.

Public Health Relevance

Fatty liver disease is poorly understood and the factors that promote liver damage in this disease have not been identified. This application investigates the hypothesis that the amount of saturated fatty acids delivered to or stored within the liver contribution to disease progression.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Doo, Edward
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Colorado State University-Fort Collins
Other Domestic Higher Education
Fort Collins
United States
Zip Code
Stewart, Claire; Estrada, Andrea; Kim, Paul et al. (2017) Regulation of IRE1? by the small molecule inhibitor 4?8c in hepatoma cells. Endoplasmic Reticulum Stress Dis 4:1-10
Pagliassotti, Michael J; Estrada, Andrea L; Hudson, William M et al. (2017) Trehalose supplementation reduces hepatic endoplasmic reticulum stress and inflammatory signaling in old mice. J Nutr Biochem 45:15-23
Pagliassotti, Michael J; Kim, Paul Y; Estrada, Andrea L et al. (2016) Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. Metabolism 65:1238-46
Gentile, C L; Weir, T L; Cox-York, K A et al. (2015) The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte 4:101-12
Nivala, Angela M; Reese, Lauren; Frye, Melinda et al. (2013) Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats. Metabolism 62:753-60
Ellis, F; Nivala, A; Pfaffenbach, K T et al. (2012) C-reactive protein does not impair insulin suppression of glucose release in primary hepatocytes. Nutr Metab Cardiovasc Dis 22:115-9
Gentile, Christopher L; Nivala, Angela M; Gonzales, Jon C et al. (2011) Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 301:R1710-22
Gentile, Christopher L; Frye, Melinda A; Pagliassotti, Michael J (2011) Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. Biofactors 37:8-16
Pfaffenbach, Kyle T; Nivala, Angela M; Reese, Lauren et al. (2010) Rapamycin inhibits postprandial-mediated X-box-binding protein-1 splicing in rat liver. J Nutr 140:879-84
Pfaffenbach, Kyle T; Gentile, Christopher L; Nivala, Angela M et al. (2010) Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am J Physiol Endocrinol Metab 298:E1027-35

Showing the most recent 10 out of 12 publications